Shares Bazaar

Cipla Ltd.   (BSE: CIPLA)

NSE   0.00  
OPEN PRICE(₹)
0.00
HIGH PRICE(₹)
0.00
LOW PRICE(₹)
0.00
CLOSE PRICE(₹)
0.00
VOLUME
0.00
52 WK LOW (₹)
644.25 (28-07-2020)
52 WK HIGH (₹)
997 (30-06-2021)
BSE   1071  
OPEN PRICE₹)
1065
HIGH PRICE(₹)
1092.8
LOW PRICE (₹)
1063.4
CLOSE PRICE(₹)
1071
VOLUME
87304
VALUE
93502600
BID QTY
0
OFFER QTY
0

Stock Summary

Trade Value (₹ in Lacs) : 1612.92 MCap (₹ in Mn) : 678676.79 Dividend Yield(%) : 0.48 Price/Earning (TTM) : 30.26
TTM EPS (₹) : 0 Price/Sales (TTM) : 0 P/E Ratio : 0.01 Price/Book (MRQ) : 3.6
Book Value(₹) : 0 Face Value(₹) : 0 Latest Reserve (₹ in Mn): 186780.9 EPSc : 28.75
PE : 29.27 TTMNP : 22427.3 TTMTAX : 6734.6 TTMINTEREST : 446.9
TTMDEPRECIATION : 5880.9 TTMNetSales : 126106.8 EV_Sales : 5.34 EV (in Mn) : 673506.69
TTMEBITDA : 35489.7 EV_EBITDA : 18.98 TTMCashProfit : 28308.2 TTMCEPS : 35.1
Price_CEPS : 23.97 TTMNPAEX : 22427.3

Peer Group Compare

Comp. Name Price M.Cap Div Yld % P/E Ratio Price/Earning (TTM) TTM EPS (₹)
Sun Pharmaceutical Industries Ltd. (BSE)

920.8 ( 1.53%)

135418.47 0.71 0 47 12.01
Divis Laboratories Ltd. (BSE)

3641.9 ( 1.71%)

91003.96 0.47 0.06 51.76 66.23
Dr. Reddys Laboratories Ltd. (BSE)

4139.5 ( -1.04%)

81092.78 0.51 0.04 33.02 147.67
Aurobindo Pharma Ltd. (BSE)

517.45 ( -0.59%)

55333.11 0.32 0.01 20.8 45.4
Lupin Ltd. (BSE)

648.45 ( -2.23%)

47639.05 0.57 0.01 54.89 19.13

Management Info

Chairman : Y K Hamied
Managing Director : Umang Vohra
Company Secretory : Rajendra Chopra
Incorporation Year : 1935

Registered Office

Address : Cipla House
Peninsula Business Park
Ganpatrao Kadam Marg, Lower Parel
City-Pincode : Mumbai-400013
Phone : 022-24826000 / 022-24826951
Website : www.cipla.com
Email : cosecretary@cipla.com

Registrars Details

Registrars Details : K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Address : Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: einward.ris@karvy.comWebsite: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001
Listing : BSE, NSE, Luxembourg, MCX

Balance Sheet

(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
SOURCES OF FUNDS:
Share Capital 0.16 0.16 0.16 0.16 0.16
  Equity - Authorised 0.18 0.18 0.18 0.18 0.18
  Equity - Issued 0.16 0.16 0.16 0.16 0.16
 Equity Paid Up 0.16 0.16 0.16 0.16 0.16
  Equity Shares Forfeited 0.00 0.00 0.00 0.00 0.00
  Adjustments to Equity 0.00 0.00 0.00 0.00 0.00
  Preference Capital Paid Up 0.00 0 0 0.00 0
  Face Value 0 0 0 0 0
Share Warrants & Outstandings 0.00 0.00 0.00 0.00 0.00
Total Reserves 15.55 14.79 14 12.32 11.27
  Securities Premium 1.6 1.57 1.54 1.51 1.45
  Capital Reserves -0.15 0.18 0.02 -0.04 -0.06
  Profit & Loss Account Balances 11.12 10.25 9 7.77 6.95
  General Reserves 3.14 3.14 3.14 3.14 3.14
Reserve excluding Revaluation Reserve 15.55 14.79 14 12.32 11.27
Revaluation Reserves 0.00 0 0 0.00 0
Deposits 0.00 0.00 0.00 0.00 0.00
  Demand Deposits 0.00 0.00 0.00 0.00 0.00
  Savings Deposit 0.00 0.00 0.00 0.00 0.00
  Term Deposits / Fixed Deposits 0.00 0.00 0.00 0.00 0.00
  Current Deposits 0.00 0.00 0.00 0.00 0.00
  Recurring Deposits 0.00 0.00 0.00 0.00 0.00
  Other Deposits 0.00 0.00 0.00 0.00 0.00
Borrowings 0.00 0.00 0.00 0.00 0.00
  Borrowings From Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Banks 0.00 0.00 0.00 0.00 0.00
  Borrowings From GOI 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Financial Institutions 0.00 0.00 0.00 0.00 0.00
  Borrowings in the form of Bonds / Debentures 0.00 0.00 0.00 0.00 0.00
  Borrowings in Other Form 0.00 0.00 0.00 0.00 0.00
Other Liabilities & Provisions 0.00 0.00 0.00 0.00 0.00
  Bills Payable 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Liabilities 0.00 0.00 0.00 0.00 0.00
  Interest Accrued 0.00 0.00 0.00 0.00 0.00
  Proposed Dividend 0.00 0.00 0.00 0.00 0.00
  Corporate dividend tax payable 0.00 0.00 0.00 0.00 0.00
  Other Liabilities & Provisions 0.13 0.12 0.14 0.14 0.14
Total Liabilities 18.9 19.77 18.53 16.91 12.38
APPLICATION OF FUNDS :
Cash and balance with Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Cash with RBI 0.00 0.00 0.00 0.00 0.00
  Cash in hand & others 0.00 0.00 0.00 0.00 0.00
Balances with banks and money at call 0.00 0.00 0.00 0.00 0.00
Investments 2.35 3.24 2.03 1.73 1.36
Investments in India 0.00 0.00 0.00 0.00 0.00
  GOI/State Govt. Securities 0.00 0.00 0.00 0.00 0.00
  Equity Shares - Corporate 0.00 0.00 0.00 0.00 0.00
  Debentures & Bonds 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures/Associates 0.00 0.00 0.00 0.00 0.00
  Units - MF/ Insurance/CP/PTC 0.00 0.00 0.00 0.00 0.00
Investments outside India 0.00 0.00 0.00 0.00 0.00
  Government securitiesC 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures abroad 0.00 0.00 0.00 0.00 0.00
  Other investments outside India 0.00 0.00 0.00 0.00 0.00
  Less: Prov for Diminution in Value of Invest. 0.00 0.00 0.00 0.00 0.00
Advances 0.00 0.00 0.00 0.00 0.00
  Bills Purchased & Discounted 0.00 0.00 0.00 0.00 0.00
  Cash Credit, Over Draft & Loans repayable 0.00 0.00 0.00 0.00 0.00
  Term Loans 0.00 0.00 0.00 0.00 0.00
  Finance lease and hire purchase receivable 0.00 0.00 0.00 0.00 0.00
Gross block 15.01 13.79 12.96 11.37 10.17
  Premises 2.86 2.55 2.55 2.25 2.03
  Assets Given on Lease 0.00 0.00 0.00 0.02 0.00
  Other Fixed Assets 0.00 0.00 0.00 0.00 0.00
Less: Accumulated Depreciation 5.41 4.23 3.01 1.61 0.8
Net Block 9.56 9.55 9.95 9.51 9.37
Less: Impairment of Assets 0.05 0.01 0.00 0.25 0.00
Lease Adjustment 0.00 0.00 0.00 0.00 0.00
Capital Work in Progress 0.82 0.68 0.98 1.68 2.06
Other Assets 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Assets 0.00 0.00 0.00 0.00 0.00
  Interest Accrued Assets 0.00 0.00 0.00 0.00 0.00
  Tax paid in advance/TDS 0.00 0.00 0.00 0.00 0.00
  Stationery and stamps 0.00 0.00 0.00 0.00 0.00
  Non-banking assets acquired 0.00 0.00 0.00 0.00 0.00
  Deferred tax asset 0.00 0.00 0.00 0.00 0.00
  Miscellaneous Expenditure not written off 0.00 0.00 0.00 0.00 0.00
Total Assets 18.9 19.77 18.53 16.91 12.38
Contingent Liabilities 0.76 0.82 0.77 0.87 0.48
  Claims not acknowledged as debts 0.51 0.64 0.63 0.69 0.32
  Outstanding forward exchange contracts 0.00 0.00 0.00 0.00 0.00
  Guarantees given in India 0.00 0.00 0.00 0.00 0.00
  Guarantees given Outside India 0.00 0.00 0.00 0.00 0.00
  Acceptances, endorsements & other obligations 0.00 0.00 0.00 0.00 0.00
Bills for collection 0.00 0.00 0.00 0.00 0.00
Book Value 0.19 0.19 0.18 0.16 0.14
Adjusted Book Value 0.19 0.19 0.18 0.16 0.14
(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
SOURCES OF FUNDS:
Share Capital 0.16 0.16 0.16 0.16 0.16
  Equity - Authorised 0.18 0.18 0.18 0.18 0.18
  Equity - Issued 0.16 0.16 0.16 0.16 0.16
 Equity Paid Up 0.16 0.16 0.16 0.16 0.16
  Equity Shares Forfeited 0.00 0.00 0.00 0.00 0.00
  Adjustments to Equity 0.00 0.00 0.00 0.00 0.00
  Preference Capital Paid Up 0.00 0.00 0.00 0.00 0.00
  Face Value 0 0 0 0 0
Share Warrants & Outstandings 0.00 0.00 0.00 0.00 0.00
Total Reserves 17.21 15.58 13.9 12.58 11.74
  Securities Premium 1.6 1.57 1.54 1.51 1.45
  Capital Reserves 0 0 0 0 0
  Profit & Loss Account Balances 12.48 10.83 9.21 7.93 7.15
  General Reserves 3.14 3.14 3.14 3.14 3.14
Reserve excluding Revaluation Reserve 17.21 15.58 13.9 12.58 11.74
Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
Deposits 0.00 0.00 0.00 0.00 0.00
  Demand Deposits 0.00 0.00 0.00 0.00 0.00
  Savings Deposit 0.00 0.00 0.00 0.00 0.00
  Term Deposits / Fixed Deposits 0.00 0.00 0.00 0.00 0.00
  Current Deposits 0.00 0.00 0.00 0.00 0.00
  Recurring Deposits 0.00 0.00 0.00 0.00 0.00
  Other Deposits 0.00 0.00 0.00 0.00 0.00
Borrowings 0.00 0.00 0.00 0.00 0.00
  Borrowings From Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Banks 0.00 0.00 0.00 0.00 0.00
  Borrowings From GOI 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Financial Institutions 0.00 0.00 0.00 0.00 0.00
  Borrowings in the form of Bonds / Debentures 0.00 0.00 0.00 0.00 0.00
  Borrowings in Other Form 0.00 0.00 0.00 0.00 0.00
Other Liabilities & Provisions 0.00 0.00 0.00 0.00 0.00
  Bills Payable 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Liabilities 0.00 0.00 0.00 0.00 0.00
  Interest Accrued 0.00 0.00 0.00 0.00 0.00
  Proposed Dividend 0.00 0.00 0.00 0.00 0.00
  Corporate dividend tax payable 0.00 0.00 0.00 0.00 0.00
  Other Liabilities & Provisions 0.11 0.11 0.12 0.13 0.13
Total Liabilities 17.67 16.01 14.36 13.05 12.25
APPLICATION OF FUNDS :
Cash and balance with Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Cash with RBI 0.00 0.00 0.00 0.00 0.00
  Cash in hand & others 0.00 0.00 0.00 0.00 0.00
Balances with banks and money at call 0.00 0.00 0.00 0.00 0.00
Investments 7.87 6.53 5.37 5.05 4.93
Investments in India 0.00 0.00 0.00 0.00 0.00
  GOI/State Govt. Securities 0.00 0.00 0.00 0.00 0.00
  Equity Shares - Corporate 0.00 0.00 0.00 0.00 0.00
  Debentures & Bonds 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures/Associates 0.00 0.00 0.00 0.00 0.00
  Units - MF/ Insurance/CP/PTC 0.00 0.00 0.00 0.00 0.00
Investments outside India 0.00 0.00 0.00 0.00 0.00
  Government securitiesC 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures abroad 0.00 0.00 0.00 0.00 0.00
  Other investments outside India 0.00 0.00 0.00 0.00 0.00
  Less: Prov for Diminution in Value of Invest. 0.00 0.00 0.00 0.00 0.00
Advances 0.00 0.00 0.00 0.00 0.00
  Bills Purchased & Discounted 0.00 0.00 0.00 0.00 0.00
  Cash Credit, Over Draft & Loans repayable 0.00 0.00 0.00 0.00 0.00
  Term Loans 0.00 0.00 0.00 0.00 0.00
  Finance lease and hire purchase receivable 0.00 0.00 0.00 0.00 0.00
Gross block 6.56 6.09 5.75 5.15 4.27
  Premises 1.97 1.95 1.97 1.88 1.68
  Assets Given on Lease 0.00 0.00 0.00 0.00 0.00
  Other Fixed Assets 0.00 0.00 0.00 0.00 0.00
Less: Accumulated Depreciation 2.52 1.96 1.43 0.92 0.44
Net Block 4.02 4.13 4.32 4.24 3.83
Less: Impairment of Assets 0.02 0 0 0 0
Lease Adjustment 0.00 0.00 0.00 0.00 0.00
Capital Work in Progress 0.32 0.3 0.46 0.56 0.55
Other Assets 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Assets 0.00 0.00 0.00 0.00 0.00
  Interest Accrued Assets 0.00 0.00 0.00 0.00 0.00
  Tax paid in advance/TDS 0.00 0.00 0.00 0.00 0.00
  Stationery and stamps 0.00 0.00 0.00 0.00 0.00
  Non-banking assets acquired 0.00 0.00 0.00 0.00 0.00
  Deferred tax asset 0.00 0.00 0.00 0.00 0.00
  Miscellaneous Expenditure not written off 0.00 0.00 0.00 0.00 0.00
Total Assets 17.67 16.01 14.36 13.05 12.25
Contingent Liabilities 2.83 4.55 4.29 4.36 4.12
  Claims not acknowledged as debts 0.5 0.49 0.49 0.53 0.32
  Outstanding forward exchange contracts 0.00 0.00 0.00 0.00 0.00
  Guarantees given in India 0.00 0.00 0.00 0.00 0.00
  Guarantees given Outside India 0.00 0.00 0.00 0.00 0.00
  Acceptances, endorsements & other obligations 0.00 0.00 0.00 0.00 0.00
Bills for collection 0.00 0.00 0.00 0.00 0.00
Book Value 0.22 0.2 0.17 0.16 0.15
Adjusted Book Value 0.22 0.2 0.17 0.16 0.15

Quarterly Results

Particulars Sep-2020 Jun-2020 Mar-2020 Feb-2019
Date End Audited Audited Audited Audited
Interest Earned 50382.90 43461.60 43761.90 43710.00
Income On Investments 0.00 0.00 0.00 0.00
Interest On Balances With Rbi Other Inter Bank Funds 0.00 0.00 0.00 0.00
Interest / Discount On Advances / Bills 0 0 0 0
Others 0 0 0 0
Other Income 534.7 654.5 931.8 721.3
Total Income 50917.6 44116.1 44693.7 44431.3
Interest Expended 393.3 460 530 461.7
Operating Expenses 0 0 0 0
Total Expenditure 38617.2 32974.2 37426.7 36126.7
Operating Profit Before Provisions and Contingencies 12300.4 11141.9 7267 8304.6
Exceptional Items 0 0 0 0
Provisions and contingencies 0 0 0 0
Profit Before Tax 9256.5 7992.1 3279 5064
Tax 2638 2277.8 855.9 1528.2
Profit After Tax 6618.5 5714.3 2423.1 3535.8
+/- Extraordinary Items 0 0 0 0
+/- Prior period items 0 0 0 0
Net Profit 6618.5 5714.3 2423.1 3535.8
Minority Interest 60.8 118.7 74.6 116.5
Shares of Associates -25 -53.9 -38.2 -142
Other related items 0 0 0 0
Misc. Expenses Written off 0.00 0.00 0.00 0.00
Consolidated Net Profit 6618.5 5714.3 2423.1 3535.8
Equity Capital 6654.3 5779.1 2459.5 3510.3
Face Value (IN RS) 2 2 2 2
Reserves 0 0 0 0
% of Shares held by Govt 0 0 0 0
Capital Adequacy Ratio 0.00 0.00 0.00 0.00
Gross / Net NPAs 0.00 0.00 0.00 0.00
Amount of Gross NPAs 0.00 0.00 0.00 0.00
Amount of Net NPAs 0 0 0 0
% of Gross / Net NPAs NA NA NA NA
% of Net NPAs 0 0 0 0
% of Gross NPAs 0 0 0 0
Return on Assets 0 0 0 0
No of Public Share Holdings NA NA NA NA
% of Public Share Holdings NA NA NA NA
Basic Eps After Extraordinary Items 8.25 7.17 3.05 4.35
Basic Eps Before Extraordinary Items 8.25 7.17 3.05 4.35
PBIDTM% 24.41 25.64 16.61 19
PBDTM% 23.63 24.58 15.39 17.94
PBTM% 18.37 18.39 7.49 11.59
PATM% 13.14 13.15 5.54 8.09
Particulars Sep-2020 Jun-2020 Mar-2020
Date End Audited Audited Audited
Interest Earned 38078.9 31280.2 31334.4
Income On Investments 0 0 0
Interest On Balances With Rbi Other Inter Bank Funds 0 0 0
Interest / Discount On Advances / Bills 0 0 0
Others 0.00 0.00 0.00
Other Income 391.7 456.6 4134.1
Total Income 38470.6 31736.8 35468.5
Interest Expended 116.9 142.1 92.4
Operating Expenses 0.00 0.00 0.00
Total Expenditure 26769.2 21832.8 26686.4
Operating Profit Before Provisions and Contingencies 11701.4 9904 8782.1
Exceptional Items 0 0 0
Provisions and contingencies 0.00 0.00 0.00
Profit Before Tax 10176.5 8324.6 7085.5
Tax 2720.1 2221.6 1039.8
Profit After Tax 7456.4 6103 6045.7
+/- Extraordinary Items 0.00 0.00 0.00
+/- Prior period items 0.00 0.00 0.00
Net Profit 7456.4 6103 6045.7
Minority Interest 0.00 0.00 0.00
Shares of Associates 0.00 0.00 0.00
Other related items 0.00 0.00 0.00
Misc. Expenses Written off 0.00 0.00 0.00
Consolidated Net Profit 7456.4 6103 6045.7
Equity Capital 7456.4 6103 6045.7
Face Value (IN RS) 2 2 2
Reserves 0 0 0
% of Shares held by Govt 0.00 0.00 0.00
Capital Adequacy Ratio 0.00 0.00 0.00
Gross / Net NPAs 0.00 0.00 0.00
Amount of Gross NPAs 0.00 0.00 0.00
Amount of Net NPAs 0.00 0.00 0.00
% of Gross / Net NPAs NA NA NA
% of Net NPAs 0.00 0.00 0.00
% of Gross NPAs 0.00 0.00 0.00
Return on Assets 0.00 0.00 0.00
No of Public Share Holdings NA NA NA
% of Public Share Holdings NA NA NA
Basic Eps After Extraordinary Items 9.25 7.57 7.5
Basic Eps Before Extraordinary Items 9.25 7.57 7.5
PBIDTM% 30.73 31.66 28.03
PBDTM% 30.42 31.21 27.73
PBTM% 26.72 26.61 22.61
PATM% 19.58 19.51 19.29

Profit-Loss

-
Particulars
-
Particulars

Financial Ratios

Particulars
Particulars

Cash Flow

(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Net Profit Before Taxes 2.18 2.08 1.67 1.22 1.73
Adjustments for Expenses & Provisions : 1.37 1.27 1.29 1.37 0.95
Adjustments for Liabilities & Assets: 0.37 -1.06 -0.78 0.24 -0.43
Refund/(payment) of direct taxes -0.85 -0.59 -0.72 -0.45 -0.51
Other Direct payments 0 0 0 0 0
Cash Flow from operating activities 3.07 1.69 1.46 2.38 1.74
Cash Flow from investing activities 0.1 -1.67 -0.85 -1.31 -4.52
Cash Flow from financing activities -2.95 -0.35 -0.39 -1.33 3.1
Effect of exchange fluctuation on translation reserve 0 0 0 0 0
Net increase/(decrease) in cash and cash equivalents 0.22 -0.33 0.22 -0.25 0.32
Opening Cash & Cash Equivalents 0.51 0.85 0.61 0.86 0.55
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0.01 -0.02 0.02 0.01 -0.01
Closing Cash & Cash Equivalent 0.74 0.51 0.85 0.61 0.86
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0.01 -0.02 0.02 0.01 -0.01
(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Net Profit Before Taxes 2.18 2.08 1.67 1.22 1.73
Adjustments for Expenses & Provisions : 1.37 1.27 1.29 1.37 0.95
Adjustments for Liabilities & Assets: 0.37 -1.06 -0.78 0.24 -0.43
Refund/(payment) of direct taxes -0.85 -0.59 -0.72 -0.45 -0.51
Other Direct payments 0 0 0 0 0
Cash Flow from operating activities 3.07 1.69 1.46 2.38 1.74
Cash Flow from investing activities 0.1 -1.67 -0.85 -1.31 -4.52
Cash Flow from financing activities -2.95 -0.35 -0.39 -1.33 3.1
Effect of exchange fluctuation on translation reserve 0 0 0 0 0
Net increase/(decrease) in cash and cash equivalents 0.22 -0.33 0.22 -0.25 0.32
Opening Cash & Cash Equivalents 0.51 0.85 0.61 0.86 0.55
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0.01 -0.02 0.02 0.01 -0.01
Closing Cash & Cash Equivalent 0.74 0.51 0.85 0.61 0.86
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0.01 -0.02 0.02 0.01 -0.01

Share Price

Year Open Price (₹) High Price (₹) Low Price (₹) Close Price (₹) Volume (000's) Value (in Lakhs)
February-2021 818.5 878.55 785.55 849.3 2622.57 22124.41
January-2021 823.35 869.65 796.35 825.6 2917.68 24348.28
December-2020 750.35 838.95 746.65 823.65 4929.31 38917.63
November-2020 758 805 706.45 744.65 6503.64 48785.47
October-2020 771 829 742.5 754.1 5675.56 44339.12
September-2020 710.1 819 701.5 774.75 7819.36 59637.44
August-2020 725 814.45 700.9 712.1 8378.53 63789.08
Cipla moves up on getting EIR from USFDA for Indore plant 23-Sep-2022 10:11 AM  
Cipla gets EIR from USFDA for Indore plant23-Sep-2022 09:59 AM  
Cipla informs about allotment under ESOP14-Sep-2022 02:58 PM  
Cipla informs about analyst meet13-Sep-2022 11:50 AM  
Cipla jumps on receiving USFDA’s approval for Lenalidomide Capsule07-Sep-2022 03:01 PM  
Cipla receives USFDA’s approval for Lenalidomide Capsule07-Sep-2022 02:51 PM  
Cipla’s arm to pick up 13.10% stake in Jiangsu01-Sep-2022 11:06 AM  
Cipla dissolves step down wholly owned subsidiary29-Aug-2022 10:48 AM  
Cipla gets 6 observations from USFDA for Goa plant29-Aug-2022 09:48 AM  
Cipla informs about updates27-Aug-2022 11:57 AM  
Cipla informs about dissolution of step-down wholly owned subsidiary27-Aug-2022 11:32 AM  
Cipla informs about outcome of AGM27-Aug-2022 11:29 AM  
Cipla informs about voting results of AGM 27-Aug-2022 11:19 AM  
Cipla’s arm recalls 7992 bottles of Difluprednate Ophthalmic Emulsion in US market22-Aug-2022 09:57 AM  
Cipla informs about allotment of equity shares17-Aug-2022 04:50 PM